European Archives - Page 319 of 1334 - European Medical Journal

Propranolol’s Surprising Role in Reducing Parkinson’s Tremor

New research shows propranolol reduces Parkinson’s tremor and motor cortex activity, offering a potential treatment option.

Key Metabolic Vulnerability in Multiple Myeloma Treatment

New research identifies VLCFA metabolism as a target to boost multiple myeloma treatment efficacy and combat drug resistance.

Study Confirms Type 2 Diabetes Raises Heart Risks in Atherosclerosis

A new study has confirmed that type 2 diabetes significantly increases the risk of major cardiovascular events, regardless of atherosclerosis severity.

COVAIL Trial Reveals Insights Into Antibody Levels and Vaccine Efficacy

New data from the COVAIL trial highlight the importance of neutralizing antibody titers in reducing COVID-19 risk after mRNA boosters, with stronger protection observed in individuals with prior SARS-CoV-2 infection.

Vaccine Shows Promise for Chronic Hepatitis B Treatment

A clinical trial was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.

Heavy Alcohol Consumption Linked to Cryptogenic Ischaemic Stroke Risk in Young Men

Heavy alcohol consumption, particularly binge drinking, is a significant risk factor for cryptogenic ischaemic stroke in young men.

Juvenile Idiopathic Arthritis: Biologic Treatments Reduce TMJ Inflammation

A new study shows that biologic treatments significantly reduce inflammation and improve jaw function in children with juvenile idiopathic arthritis (JIA) affecting the temporomandibular joint (TMJ).

Fivefold Increase in Severe Maternal Morbidity Linked to Preeclampsia

Severe maternal morbidity risk is five times higher with preeclampsia, underscoring the need for prevention in chronic hypertension.

Breakthrough in Ovarian Carcinoma Subtyping with AI Models

AI foundation models boost ovarian carcinoma subtyping accuracy, providing clinicians with valuable diagnostic support and efficiency.

Novel Tool Diagnoses Tuberculosis in Low-Prevalence Areas

A novel clinical decision support system, TBorNotTB, has been developed to assist clinicians in diagnosing pulmonary tuberculosis in low-prevalence settings.